C. Michalski

Publications238
h-index45
Citations8,480
Highly Influential Citations281
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • M. Büchler
  • 2,459 Publications • 100,429 Citations
  • H. Friess
  • 1,591 Publications • 73,432 Citations
  • J. Kleeff
  • 558 Publications • 25,051 Citations
  • R. Hruban
  • 1,308 Publications • 153,060 Citations
  • Publications
  • Influence
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors
TLDR
It is concluded that the contribution of CB1-type receptors expressed on the peripheral terminals of nociceptors to cannabinoid-induced analgesia is paramount, which should enable the development of peripherally acting CB1 analgesic agonists without any central side effects.
View on Nature
The role of stroma in pancreatic cancer: diagnostic and therapeutic implications
TLDR
Targeting the tumour stroma, in combination with chemotherapy, is a promising new option for the treatment of PDAC.
View on Nature
Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer.
View on PubMed
StellaTUM: current consensus and discussion on pancreatic stellate cell research
TLDR
Members of the Pancreatic Star Alliance discuss and consolidate current knowledge to outline and delineate areas of consensus or otherwise (eg, with regard to methodological approaches) and, more importantly, to identify essential directions for future research.
View on BMJ
The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma.
View on PubMed
Hematopoietic colony–stimulating factors mediate tumor-nerve interactions and bone cancer pain
TLDR
Results show that G- CSF and GM-CSF are important in tumor-nerve interactions and suggest that their receptors on primary afferent nerve fibers constitute potential therapeutic targets in cancer pain.
View on Nature
Locally Advanced Pancreatic Cancer: Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the Patients
TLDR
Folfirinox seems to be the most effective protocol resulting in a significantly better secondary resection rate and overall survival than other treatments and should be considered in all patients fit for this regimen and consecutive surgical exploration.
View on Wolters Kluwer
Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma.
TLDR
Although PSCs are the dominant producers of VEGF and increase endothelial cell growth in vitro, in the peritumoral stroma, they contribute to the fibrotic/hypoxic milieu through abnormal extracellular matrix deposition and by amplifying endostatin production of cancer cells.
View PDF
Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer
TLDR
A novel lncRNA, sncRNA and mRNA signature of PDAC is reported, which allows for assigning potential functions to differentially regulated RNAs.
View on Springer
Cannabinoids in pancreatic cancer: Correlation with survival and pain
TLDR
Evaluation of immunoreactivity for cannabinoid‐1 and cannabinoid‐2 receptors as well as for the endocannabinoid metabolizing enzymes fatty acid amide hydrolase (FAAH) and monoacyl glycerol lipase (MGLL) revealed that these remained unchanged in PDAC compared to the normal pancreas.
View on Wiley
...
...